According to information from the editorial network Germany, the Standing Vaccination Commission (Stiko) tends to refrain from a general corona vaccination recommendation for twelve to 15-year-olds. Instead, there will probably only be a recommendation for those of this age group who suffer from certain chronic diseases, report the newspapers of the editorial network. The reason for this approach is, among other things, an unsatisfactory data situation in order to be able to weigh up the consequences of corona disease for this age group and the possible risks of a vaccination, the papers continue.
The deputy chairman of the SPD parliamentary group, Bärbel Bas, who is responsible for health issues, also expects such a procedure. She told the newspapers, “I expect Stiko will make a list of diseases for which it recommends vaccinating children.” Bas said children with these diseases would have to be vaccinated first. “This must now be ensured despite the cancellation of the prioritization.” School openings shouldn’t be made dependent on whether children are vaccinated, Bas added.
“The vaccination is a medical procedure – not a candy”
The Stiko chairman Thomas Mertens had previously said on Deutschlandfunk: “Our primary goal must be the protection and well-being of children.” The other arguments, such as the opening of schools or participation in life or in the parents’ holidays, are secondary arguments. After all, during the vaccinations, “no sweets are distributed”, but a medical intervention is carried out. Other measures could possibly be a better solution.
Health Minister Jens Spahn would like to offer vaccinations to all children aged twelve and over by the end of August
–
Federal Minister of Health Jens Spahn and Federal Minister of Education Anja Karliczek (both CDU) had recently campaigned for a swift vaccination of children and adolescents in order to enable them to return to regular classes in the new school year in the corona pandemic.
However, none of the vaccines available in Germany have yet been approved for people under the age of 16. A decision by the European Medicines Agency (EMA) on approval of the German-American preparation from BioNTech / Pfizer for children from the age of twelve could be made by the end of May. In the USA and Canada, the vaccine is already approved for twelve to 15 year olds.
se / fw (afp, dpa, rtr)
– .
